Your browser doesn't support javascript.
loading
Ravidasvir: equitable access through an alternative drug development pathway.
Cheong, Mark Wing Loong; Piedagnel, Jean-Michel; Khor, Swee Kheng.
Affiliation
  • Cheong MWL; School of Pharmacy, Monash University Malaysia, Bandar Sunway 47500, Malaysia; United Nations University-International Institute for Global Health, Cheras, Malaysia. Electronic address: cheong.wingloong@monash.edu.
  • Piedagnel JM; Southeast Asia Regional Office, Drugs for Neglected Diseases initiative, Kuala Lumpur, Malaysia.
  • Khor SK; United Nations University-International Institute for Global Health, Cheras, Malaysia; Chatham House Royal-Institute of International Affairs, London, UK.
Lancet Glob Health ; 9(11): e1496-e1497, 2021 11.
Article in En | MEDLINE | ID: mdl-34678186
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Valine / Benzimidazoles / Hepatitis C / Drug Development Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Glob Health Year: 2021 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Valine / Benzimidazoles / Hepatitis C / Drug Development Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Glob Health Year: 2021 Document type: Article Country of publication: United kingdom